Sequential assessments of KRAS-mutated circulating tumor DNA in longitudinal monitoring enable the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.

被引：1
|
作者：
Watanabe, Fumiaki
Suzuki, Koichi
Tamaki, Sawako
Ishikawa, Hideki
Kakizawa, Nao
Noda, Hiroshi
Rikiyama, Toshiki
机构：
[1] Jichi Med Univ, Saitama, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15712
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15712
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer
    Watanabe, Fumiaki
    Suzuki, Koichi
    Tamaki, Sawako
    Abe, Iku
    Endo, Yuhei
    Takayama, Yuji
    Ishikawa, Hideki
    Kakizawa, Nao
    Saito, Masaaki
    Futsuhara, Kazushige
    Noda, Hiroshi
    Konishi, Fumio
    Rikiyama, Toshiki
    PLOS ONE, 2019, 14 (12):
  • [2] Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients
    Watanabe, Fumiaki
    Suzuki, Koichi
    Tamaki, Sawako
    Abe, Iku
    Endo, Yuhei
    Takayama, Yuji
    Ishikawa, Hideki
    Kakizawa, Nao
    Saito, Masaaki
    Futsuhara, Kazushige
    Noda, Hiroshi
    Konishi, Fumio
    Rikiyama, Toshiki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients
    Fumiaki Watanabe
    Koichi Suzuki
    Sawako Tamaki
    Iku Abe
    Yuhei Endo
    Yuji Takayama
    Hideki Ishikawa
    Nao Kakizawa
    Masaaki Saito
    Kazushige Futsuhara
    Hiroshi Noda
    Fumio Konishi
    Toshiki Rikiyama
    Scientific Reports, 11
  • [4] Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma
    Guibert, Nicolas
    Pradines, Anne
    Farella, Magali
    Casanova, Anne
    Gouin, Sandrine
    Keller, Laura
    Favre, Gilles
    Mazieres, Julien
    LUNG CANCER, 2016, 100 : 1 - 4
  • [5] Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients
    Lavacchi, Daniele
    Gelmini, Stefania
    Calabri, Adele
    Rossi, Gemma
    Simi, Lisa
    Caliman, Enrico
    Mancini, Irene
    Salvianti, Francesca
    Petroni, Giulia
    Guidolin, Alessia
    Scolari, Federico
    Messerini, Luca
    Pillozzi, Serena
    Pinzani, Pamela
    Antonuzzo, Lorenzo
    HELIYON, 2023, 9 (11)
  • [6] Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring
    Perets, Ruth
    Greenberg, Orli
    Shentzer, Talia
    Semenisty, Valeria
    Epelbaum, Ron
    Bick, Tova
    Sarji, Shada
    Ben-Izhak, Ofer
    Sabo, Edmond
    Hershkovitz, Dov
    ONCOLOGIST, 2018, 23 (05): : 566 - 572
  • [7] Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer.
    Takayama, Yuji
    Suzuki, Koichi
    Fukui, Taro
    Ichida, Kosuke
    Watanabe, Fumiaki
    Kakizawa, Nao
    Kikugawa, Rina
    Hasegawa, Fumi
    Tsujinaka, Shingo
    Miyakura, Yasuyuki
    Konishi, Fumio
    Rikiyama, Toshiki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Serial circulating tumor DNA monitoring for predicting treatment response and prognosis in patients with pancreatic cancer
    Lee, Jongchan
    Ahn, Jinwoo
    Jung, Kwangrok
    Lee, Jong-Chan
    Youn, Yuna
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
    Tjensvoll, Kjersti
    Lapin, Morten
    Buhl, Tove
    Oltedal, Satu
    Berry, Katrine Steen-Ottosen
    Gilje, Bjornar
    Soreide, Jon Arne
    Javle, Millind
    Nordgard, Oddmund
    Smaaland, Rune
    MOLECULAR ONCOLOGY, 2016, 10 (04) : 635 - 643
  • [10] Comparative circulating tumor DNA levels for KRAS mutations in patients with nonresectable pancreatic cancer
    Johansen, Julia S.
    Vibat, Cecile Rose T.
    Calatayud, Dan
    Jensen, Benny Vittrup
    Hasselby, Jane Preuss
    Collisson, Eric Andrew
    Lu, Timothy
    Poole, Jason C.
    Erlander, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345